Home›Stock Screener›RPG Life Sciences›Quarterly Results

RPG Life Sciences Quarterly Results

Latest Quarter Net Profit
₹30 Cr
QMar 2026
Quarterly Results

RPG Life Sciences quarterly results. In Mar 2026, RPG Life Sciences (RPGLIFE) reported revenue ₹190 Cr and net profit ₹30 Cr — revenue -26.4% YoY. For annual financials, live price and key ratios, visit RPGLIFE share price.

RPGLIFE Quarterly Results — Revenue, Profit & EPS Highlights

RPG Life Sciences latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Review RPGLIFE P/E ratio to evaluate earnings-based valuation against sector peers.

  • Revenue of ₹190 Cr in Mar 2026 (-5.0% vs Jun 2026, -26.4% vs Mar 2025)
  • Net Profit of ₹30 Cr in Mar 2026 (-3.2% vs Jun 2026, -74.4% vs Mar 2025)
  • EBITDA of ₹46 Cr in Mar 2026 (-4.2% vs Jun 2026)
  • Operating Margin of 19.0% in Mar 2026 (-3.0pp vs Jun 2026)
  • Earnings Per Share of ₹18.08 in Mar 2026 (-2.8% vs Jun 2026)

RPG Life Sciences Quarterly Results — Revenue, EBITDA, Net Profit & EPS

RPGLIFE quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Mar 2026 Jun 2026 Sept 2025 Mar 2025 Jun 2025 QoQ YoY
Revenue (₹ Cr) 190 200 197 258 174 -5.0% -26.4%
Net Profit (₹ Cr) 30 31 37 117 26 - -
EBITDA (₹ Cr) 46 48 55 140 41 - -
EPS (₹) 18.08 18.60 22.28 70.96 15.90 - -
Operating Margin (%) 19.0% 22.0% 21.0% 18.0% 21.0% - -

RPGLIFE Share Price Trend — 1-Year Movement Across Quarterly Results

RPG Life Sciences 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Check RPG Life Sciences market worth to track the company's total market size over time.

Profitability Ratios

Profit Margin 15.8%
EBITDA Margin 24.2%
Operating Margin 19.0%
ROE (Annual) 19.8%

Balance Sheet Highlights

Total Assets ₹793 Cr
Total Equity ₹605 Cr
Current Assets ₹560 Cr
Current Liabilities ₹27 Cr

Cash Flow Analysis

Operating Cash Flow ₹57 Cr
Investing Cash Flow ₹86 Cr
Financing Cash Flow ₹-21 Cr
Net Cash Flow ₹122 Cr

Current Market Data

Current Price ₹2896.40
Exchange NSE
Last Updated Oct 05, 2026

Revenue Trend (₹ Cr)

Mar 2025 258
Sept 2025 197
Jun 2026 200
Mar 2026 190

Net Profit Trend (₹ Cr)

Mar 2025 117
Sept 2025 37
Jun 2026 31
Mar 2026 30

Operating Margin Trend (%)

Mar 2025 18.0%
Sept 2025 21.0%
Jun 2026 22.0%
Mar 2026 19.0%

RPGLIFE vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

RPG Life Sciences latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Mar 2026 		₹432,120.23 Cr 1779.7 15,018 2,710 -5.6% - 18.0% 157.5
Divis Laboratories
Mar 2026 		₹253,522.49 Cr 9196.0 2,986 751 -5.0% - 25.2% 324.8
Torrent Pharmaceuti…
Mar 2026 		₹188,719.51 Cr 4772.0 4,111 364 +27.7% +42.2% 8.9% 414.6
Zydus Life Science
Mar 2026 		₹113,615.69 Cr 1139.0 7,569 1,341 -4.3% - 17.7% 90.0
Cipla
Mar 2026 		₹108,576.18 Cr 1335.5 6,612 543 -9.3% - 8.2% 194.4
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores